Unicancer

This study tested a drug called tislelizumab in 50 adults with advanced liver cancer and moderate liver damage (Child-Pugh B). The goal was to see if the drug could shrink tumors and how safe it was. Participants received tislelizumab alone, and the study measured how many had th…

This study tested whether a combination of two chemotherapy drugs (gemcitabine and paclitaxel) helps people with advanced pancreatic cancer live longer compared to gemcitabine alone. The 211 participants had already tried and failed or couldn't tolerate the standard first treatme…

This study looked at women with a common type of advanced breast cancer that has spread. They were all taking a hormone pill (aromatase inhibitor) and a targeted drug called palbociclib. The study used a blood test to find when a specific gene mutation (ESR1) appeared, which can …

This study tested two chemotherapy regimens (mFOLFIRINOX and mFOLFOX) in 792 patients with high-risk stage III colon cancer who had surgery to remove the tumor. The goal was to see which combination better prevents the cancer from coming back. Participants received one of the two…

This study tested whether adding the immunotherapy drug durvalumab to standard chemoradiation helps people with unresectable esophageal cancer. 112 participants received either chemoradiation alone or chemoradiation plus durvalumab, followed by durvalumab maintenance. The main go…

This study looked at 132 adults with oral or throat cancer who needed jawbone removal and reconstruction using a bone flap from the leg. Half had standard surgery, and half had surgery planned with 3D virtual tools. The main goal was to see if virtual planning improved quality of…

This study looked at why women aged 65 and older with early-stage breast cancer chose one of three options after surgery: standard weeks-long radiation, a single dose during surgery, or no radiation at all. Researchers surveyed 104 patients to understand their reasons and experie…